Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
A retrovirus belonging to the family of recently discovered human T-cell leukemia viruses (HTLV), but clearly distinct from each previous isolate, has been isolated from a Caucasian patient with signs and symptoms that often precede the acquired immune deficiency syndrome (AIDS). This virus is a typical type-C RNA tumor virus, buds from the cell membrane, prefers magnesium for reverse transcriptase activity, and has an internal antigen (p25) similar to HTLV p24. Antibodies from serum of this patient react with proteins from viruses of the HTLV-I subgroup, but type-specific antisera to HTLV-I do not precipitate proteins of the new isolate. The virus from this patient has been transmitted into cord blood lymphocytes, and the virus produced by these cells is similar to the original isolate. From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About two and a half years later, the virus now known as HIV was isolated from an AIDS patient in France, again with its RT as the definitive piece of evidence for its retroviral identity (106).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [106]
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
Morbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D., & Gallo, R. C. (1982) · Science · doi:10.1126/science.6981847 · Cited by 1,196
Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)
Popovic, M., Sarin, P. S., Robert-Gurroff, M., Kalyanaraman, V. S., Mann, D., Minowada, J., & Gallo, R. C. (1983) · Science · doi:10.1126/science.6600519 · Cited by 559
Immunologic abnormalities in homosexual men
Stahl, R. E., Friedman-Kien, A., Dubin, R., Marmor, M., & Zolla-Pazner, S. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90174-7 · Cited by 318
Robert-Guroff, M., Ruscetti, F. W., Posner, L. E., Poiesz, B. J., & Gallo, R. C. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.6.1957 · Cited by 260
Kalyanaraman, V. S., Sarngadharan, M. G., Poiesz, B., Ruscetti, F. W., & Gallo, R. C. (1981) · Journal of Virology · doi:10.1128/jvi.38.3.906-915.1981 · Cited by 235
DOES PREGNANCY PROTECT AGAINST OVARIAN CANCER?
Beral, V., Fraser, P., & Chilvers, C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90925-x · Cited by 191
de microbiologie., S. F. (1915) · Cited by 167
Karess, R. E., Hayward, W. S., & Hanafusa, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3154 · Cited by 128
Research works printed but not linked: 7
- NEW ENGLAND JOURNAL OF MEDICINE 306: 248 (1982).
- FANNIN, S, MMWR 31: 305 (1982).
- MARMOR, M, RISK-FACTORS FOR KAPOSIS SARCOMA IN HOMOSEXUAL MEN, LANCET 1: 1083 (1982).
- MILDVAN, D, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 249 (1982).
- OREILLY, R, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 665 (1982).
- POON, M.C., MORBIDITY AND MORTALITY WEEKLY REPORT 31: 644 (1982).
- ROZENBAUM, W, MULTIPLE OPPORTUNISTIC INFECTION IN A MALE-HOMOSEXUAL IN FRANCE, LANCET 1: 572 (1982).
Cited by
Items 101–200 of 315
Location of the Trans -Activating Region on the Genome of Human T-Cell Lymphotropic Virus Type III
Sodroski, J., Patarca, R., Rosen, C., Wong-Staal, F., & Haseltine, W. (1985) · Science · doi:10.1126/science.2990041 · Cited by 556
Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69162-9 · Cited by 555
Moss, A. R., Bacchetti, P., Osmond, D., Krampf, W., Chaisson, R. E., Stites, D., Wilber, J., Allain, J.-P., & Carlson, J. (1988) · BMJ · doi:10.1136/bmj.296.6624.745 · Cited by 544
Gender equality in science, medicine, and global health: where are we at and why does it matter?
Shannon, G., Jansen, M., Williams, K., Cáceres, C., Motta, A., Odhiambo, A., Eleveld, A., & Mannell, J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33135-0 · Cited by 534
Palker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., & Haynes, B. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1932 · Cited by 532
Zagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., Sarin, P. S., & Gallo, R. C. (1986) · Science · doi:10.1126/science.2418502 · Cited by 530
HIV infection and the gastrointestinal immune system
Brenchley, J. M., & Douek, D. C. (2008) · Mucosal Immunology · doi:10.1038/mi.2007.1 · Cited by 526
Varmus, H. (1988) · Science · doi:10.1126/science.3287617 · Cited by 523
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins
Gelderblom, H. R., Hausmann, E. H. S., Özel, M., Pauli, G., & Koch, M. A. (1987) · Virology · doi:10.1016/0042-6822(87)90449-1 · Cited by 521
AIDS in Africa: An Epidemiologic Paradigm
Quinn, T. C., Mann, J. M., Curran, J. W., & Piot, P. (1986) · Science · doi:10.1126/science.3022379 · Cited by 521
AIDS Retrovirus Induced Cytopathology: Giant Cell Formation and Involvement of CD4 antigen
Lifson, J. D., Reyes, G. R., McGrath, M. S., Stein, B. S., & Engleman, E. G. (1986) · Science · doi:10.1126/science.3010463 · Cited by 517
Alizon, M., Wain-Hobson, S., Montagnier, L., & Sonigo, P. (1986) · Cell · doi:10.1016/0092-8674(86)90860-3 · Cited by 517
Self-citationRecent progress in the development of coumarin derivatives as potent anti‐HIV agents
Yu, D., Suzuki, M., Xie, L., Morris‐Natschke, S. L., & Lee, K. (2003) · Medicinal Research Reviews · doi:10.1002/med.10034 · Cited by 515
Goudsmit, J., Paul, D., Lange, J. A., Speelman, H., Van Der Noordaa, J., Van Der Helm, H., De Wolf, F., Epstein, L., Krone, W. A., Wolters, E., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92485-2 · Cited by 512
Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages
Kyei, G. B., Dinkins, C., Davis, A. S., Roberts, E., Singh, S. B., Dong, C., Wu, L., Kominami, E., Ueno, T., Yamamoto, A., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903070 · Cited by 509
“3 I) and H9 T cells infected with the CXCR4 coreceptor using (X4, T cell tropic) virus HIVLAI (Fig.”
High resolution structures of HIV-1 RT from four RT–inhibitor complexes
Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-293 · Cited by 502
Chromones as a privileged scaffold in drug discovery: A review
Keri, R. S., Budagumpi, S., Pai, R. K., & Balakrishna, R. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.047 · Cited by 500
Pathogenesis of Infection with Human Immunodeficiency Virus
Epstein, F. H., Ho, D. D., Pomerantz, R. J., & Kaplan, J. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707303170505 · Cited by 495
Moore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
Infectious HIV-1 assembles in late endosomes in primary macrophages
Pelchen-Matthews, A., Kramer, B., & Marsh, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304008 · Cited by 494
Mechanism and fidelity of HIV reverse transcriptase.
Kati, W. M., Johnson, K. A., Jerva, L. F., & Anderson, K. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35706-5 · Cited by 492
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Human Immunodeficiency Viruses
Coffin, J., Haase, A., Levy, J. A., Montagnier, L., Oroszlan, S., Teich, N., Temin, H., Toyoshima, K., Varmus, H., Vogt, P., et al. (1986) · Science · doi:10.1126/science.3008335 · Cited by 480
Self-citationChrist, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
HIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Structural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
The Acquired Immunodeficiency Syndrome
GOTTLIEB, M. S., GROOPMAN, J. E., WEINSTEIN, W. M., FAHEY, J. L., & DETELS, R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-208 · Cited by 470
Cytokines alter production of HIV-1 from primary mononuclear phagocytes
Koyanagi, Y., O'Brien, W., Zhao, J., Golde, D., Gasson, J., & Chen, I. (1988) · Science · doi:10.1126/science.241.4873.1673 · Cited by 467
Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., & De Clercq, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6132 · Cited by 465
REVIEW : Recent advances in developing web-servers for predicting protein attributes
Chou, K.-C., & Shen, H.-B. (2009) · Natural Science · doi:10.4236/ns.2009.12011 · Cited by 464
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Chaisson, R. E., Schecter, G. F., Theuer, C. P., Rutherford, G. W., Echenberg, D. F., & Hopewell, P. C. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.3.570 · Cited by 455
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients
Weiss, R. A., Clapham, P. R., Cheingsong-Popov, R., Dalgleish, A. G., Carne, C. A., Weller, I. V. D., & Tedder, R. S. (1985) · Nature · doi:10.1038/316069a0 · Cited by 452
HIV‐associated chronic immune activation
Paiardini, M., & Müller‐Trutwin, M. (2013) · Immunological Reviews · doi:10.1111/imr.12079 · Cited by 451
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Hoffman, A. D., Banapour, B., & Levy, J. A. (1985) · Virology · doi:10.1016/0042-6822(85)90135-7 · Cited by 443
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
Sullenger, B. A., Gallardo, H. F., Ungers, G. E., & Gilboa, E. (1990) · Cell · doi:10.1016/0092-8674(90)90455-n · Cited by 443
Stevenson, M. (2003) · Nature Medicine · doi:10.1038/nm0703-853 · Cited by 441
Perils at mucosal front lines for HIV and SIV and their hosts
Haase, A. T. (2005) · Nature Reviews Immunology · doi:10.1038/nri1706 · Cited by 440
Sepkowitz, K. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442306 · Cited by 438
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1985) · Science · doi:10.1126/science.2994223 · Cited by 437
Miedema, F., Petit, A. J., Terpstra, F. G., Schattenkerk, J. K., de Wolf, F., Al, B. J., Roos, M., Lange, J. M., Danner, S. A., & Goudsmit, J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113809 · Cited by 433
The design of drugs for HIV and HCV
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2424 · Cited by 430
The origin and diversity of the HIV-1 pandemic
Hemelaar, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.001 · Cited by 427
Schwartz, S., Felber, B. K., Benko, D. M., Fenyö, E. M., & Pavlakis, G. N. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2519-2529.1990 · Cited by 423
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Ghosh, A. K., Osswald, H. L., & Prato, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01697 · Cited by 419
Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N., & Berzofsky, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3105 · Cited by 409
Epidermal Langerhans Cells-A Target for HTLV-III/LAV Infection
Tschachler, E., Groh, V., Popovic, M., Mann, D. L., Konrad, K., Safai, B., Eron, L., DiMarzo Veronese, F., Wolff, K., & Stingl, G. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12525402 · Cited by 408
Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5701-5707.1990 · Cited by 405
Modeling and analyzing HIV transmission: the effect of contact patterns
Jacquez, J. A., Simon, C. P., Koopman, J., Sattenspiel, L., & Perry, T. (1988) · Mathematical Biosciences · doi:10.1016/0025-5564(88)90031-4 · Cited by 402
Behavioral intervention to reduce AIDS risk activities.
Kelly, J. A., St. Lawrence, J. S., Hood, H. V., & Brasfield, T. L. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.57.1.60 · Cited by 402
de Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
Mitsuya, H., Popovic, M., Yarchoan, R., Matsushita, S., Gallo, R. C., & Broder, S. (1984) · Science · doi:10.1126/science.6091268 · Cited by 397
Ecological Origins of Novel Human Pathogens
Woolhouse, M., & Gaunt, E. (2007) · Critical Reviews in Microbiology · doi:10.1080/10408410701647560 · Cited by 396
Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390
Historical review of the causes of cancer
Blackadar, C. B. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.54 · Cited by 389
Buchwald, D., Cheney, P. R., Peterson, D. L., Henry, B., Wormsley, S. B., Geiger, A., Ablashi, D. V., Salahuddin, S. Z., Saxinger, C., Biddle, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-103 · Cited by 384
Challenges in the development of an HIV-1 vaccine
Barouch, D. H. (2008) · Nature · doi:10.1038/nature07352 · Cited by 380
Evaluation of Heterosexual Partners, Children, and Household Contacts of Adults With AIDS
Fischl, M. A. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390050066020 · Cited by 379
Peden, K., Emerman, M., & Montagnier, L. (1991) · Virology · doi:10.1016/0042-6822(91)90537-l · Cited by 379
Self-citationImmunohistochemical identification of HTLV‐III antigen in brains of patients with AIDS
Gabuzda, D. H., Ho, D. D., de la Monte, S. M., Hirsch, M. S., Rota, T. R., & Sobel, R. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200304 · Cited by 377
Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K., & Putney, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2107-2114.1988 · Cited by 376
Lever, A., Gottlinger, H., Haseltine, W., & Sodroski, J. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.4085-4087.1989 · Cited by 375
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Navia, B. A., & Price, R. W. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130051017 · Cited by 374
Stremlau, M., Perron, M., Welikala, S., & Sodroski, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3139-3145.2005 · Cited by 373
Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application
(1989) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(08)60182-1 · Cited by 373
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
Cohen, E. A., Dehni, G., Sodroski, J. G., & Haseltine, W. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.3097-3099.1990 · Cited by 372
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
Gougeon, M.-L., & Montagnier, L. (1993) · Science · doi:10.1126/science.8098552 · Cited by 367
Self-citationInfection of the SCID-hu Mouse by HIV-1
Namikawa, R., Kaneshima, H., Lieberman, M., Weissman, I. L., & McCune, J. M. (1988) · Science · doi:10.1126/science.3201256 · Cited by 366
Epidemiological parameters of HI V transmission
Andersen, R. M., & May, R. M. (1988) · Nature · doi:10.1038/333514a0 · Cited by 364
Direct Polyclonal Activation of Human B Lymphocytes by the Acquired Immune Deficiency Syndrome Virus
Schnittman, S. M., Lane, H. C., Higgins, S. E., Folks, T., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3016902 · Cited by 364
HTLV-III in Saliva of People with AIDS-Related Complex and Healthy Homosexual Men at Risk for AIDS
Groopman, J. E., Salahuddin, S. Z., Sarngadharan, M. G., Markham, P. D., Gonda, M., Sliski, A., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6093247 · Cited by 363
Nunberg, J. H., Schleif, W. A., Boots, E. J., O'Brien, J. A., Quintero, J. C., Hoffman, J. M., Emini, E. A., & Goldman, M. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4887-4892.1991 · Cited by 363
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.
Gendelman, H. E., Phelps, W., Feigenbaum, L., Ostrove, J. M., Adachi, A., Howley, P. M., Khoury, G., Ginsberg, H. S., & Martin, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9759 · Cited by 362
Weinberg, J. B., Matthews, T. J., Cullen, B. R., & Malim, M. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1477 · Cited by 361
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
Franchini, G. (1995) · Blood · doi:10.1182/blood.v86.10.3619.bloodjournal86103619 · Cited by 360
Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications
Hong, S., & Banks, W. A. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.008 · Cited by 360
Buonaguro, L., Tornesello, M. L., & Buonaguro, F. M. (2007) · Journal of Virology · doi:10.1128/jvi.00872-07 · Cited by 359
Barillari, G., Gendelman, R., Gallo, R. C., & Ensoli, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7941 · Cited by 356
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., & Berman, P. W. (1986) · Science · doi:10.1126/science.3014647 · Cited by 353
Witt, D. J., Craven, D. E., & McCabe, W. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90150-1 · Cited by 352
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Haynes, B. F., Wiehe, K., Borrow, P., Saunders, K. O., Korber, B., Wagh, K., McMichael, A. J., Kelsoe, G., Hahn, B. H., Alt, F., et al. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00753-w · Cited by 352
Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A., & Pavlakis, G. N. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1265-1274.1989 · Cited by 351
Cytokines and HIV-1: Interactions and Clinical Implications
Kedzierska, K., & Crowe, S. M. (2001) · Antiviral Chemistry and Chemotherapy · doi:10.1177/095632020101200301 · Cited by 350
Robey, W. G., Safai, B., Oroszlan, S., Arthur, L. O., Gonda, M. A., Gallo, R. C., & Fischinger, P. J. (1985) · Science · doi:10.1126/science.2984774 · Cited by 349
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
Page, K. A., Landau, N. R., & Littman, D. R. (1990) · Journal of Virology · doi:10.1128/jvi.64.11.5270-5276.1990 · Cited by 348
Robert-Guroff, M. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370220095034 · Cited by 347
Baba, M., Pauwels, R., Herdewijn, P., De Clercq, E., Desmyter, J., & Vandeputte, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90460-8 · Cited by 342
Specific Tropism of HIV-1 for Microglial Cells in Primary Human Brain Cultures
Watkins, B. A., Dorn, H. H., Kelly, W. B., Armstrong, R. C., Potts, A. J., Michaels, F., Kufta, C. V., & Dubois-Dalcq, M. (1990) · Science · doi:10.1126/science.2200125 · Cited by 342
Alterations in T4 (CD4) Protein and mRNA Synthesis in Cells Infected with HIV
Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J., & Reed, J. C. (1986) · Science · doi:10.1126/science.3095925 · Cited by 340
Targeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
The Acquired Immunodeficiency Syndrome: An Update
FAUCI, A. S., MASUR, H., GELMANN, E. P., MARKHAM, P. D., HAHN, B. H., & LANE, H. C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-800 · Cited by 338
Aminosugar derivatives as potential anti-human immunodeficiency virus agents.
Karpas, A., Fleet, G. W., Dwek, R. A., Petursson, S., Namgoong, S. K., Ramsden, N. G., Jacob, G. S., & Rademacher, T. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9229 · Cited by 338
Walker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
A Pathogenic Retrovirus (HTLV-III) Linked to AIDS
Broder, S., & Gallo, R. C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411153112006 · Cited by 335
Metadata
- Authors
- Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., & Montagnier, L.
- Affiliations
- Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
- Institut Pasteur (FR)
- Hôpital Claude Bernard, Laboratoire Central-Virologie, 75019 Paris
- Pitié-Salpêtrière Hospital (FR)
- ORCID
- Rozenbaum, W.
- Venue
- Science
- Published
- 1983-05-20
- Volume
- 220
- Issue
- 4599
- Pages
- 868-871
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1977282539
- Cited by
- 7,038
- References
- 13
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 135 · 2023: 124 · 2022: 130 · 2021: 159 · 2020: 129 · 2019: 141 · 2018: 138 · 2017: 111 · 2016: 146 · 2015: 167 · 2014: 192 · 2013: 193 · 2012: 210
- FWCI
- 141.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human T-cell leukemia virus, HTLV-1, AIDS, retrovirus isolation, reverse transcriptase, horizontal transmission, cord blood lymphocytes
- MeSH terms
- Chromobox Protein Homolog 5, Acquired Immunodeficiency Syndrome, Adult, Animals, Antibodies, Viral, Cells, Cultured, Humans, Male, Microscopy, Electron, Retroviridae, RNA-Directed DNA Polymerase, T-Lymphocytes, Tumor Virus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.